BioSpace News Archive

Streamlining product categories, standardization fuel non-clinical cost savings

The summit will feature experts from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

Vitalacy (www.vitalacy.com), the leading hand hygiene improvement platform, announces today that Ann Blouin, PhD, RN, MBA, FACHE, has agreed to join its board of directors.

Veloxis upgrades 2018 Outlook based on strong performance.

The Georgia Cancer Center for Excellence at Grady Health System has been recognized by the QOPI® Certification Program LLC as successfully completing a three-year certification program for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.

Unifor local 229 is pleased that the board of the Port Arthur Heath Care Centre has agreed to return to the bargaining table tomorrow.

Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an innovative, next-generation suite of pre-clinical oncology services.

ActiGraph, the leading provider of medical-grade wearable activity and sleep monitoring solutions for the global scientific community, announced today the establishment of a new Scientific Affairs and Data Management division.

Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed medications topically to the eye, today announced positive results of its EYN PG21 proof-of-concept study of microdose latanoprost for the lowering of intraocular pressure (IOP) and patient usability.